Nasdaq Informs Synutra That the Company's Filing Delinquency Has Been Cured
Accordingly, the Company's scheduled hearing before Nasdaq's Listing Qualifications Panel has been considered moot.
15/10/07 On October 10, 2007, Synutra International, Inc., one of China's leading manufacturers of dairy-based nutritional products for infants, children and adults, received a letter from the Nasdaq Stock Market stating that the Company's common stock is no longer subject to delisting following the filing with the SEC on October 5, 2007 of the Company's quarterly report on Form 10-Q for the period ended June 30, 2007. Upon review of the filing, the Nasdaq staff determined that Synutra meets all listing criteria and is in compliance with Nasdaq Marketplace Rule 4310(c)(14), which states that timely filing of annual and periodic reports with the SEC is required for continued listing. Accordingly, the Company's scheduled hearing before Nasdaq's Listing Qualifications Panel has been considered moot.
